Top

Breast Cancer Research and Treatment

Published in:

01-09-1998

Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro

Authors: Marijke Bontenbal, Anieta M. Sieuwerts, Harry A. Peters, Wim L.J. van Putten, John A. Foekens, Jan G.M. Klijn

Published in: Breast Cancer Research and Treatment | Issue 2/1998

Title: Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro
Authors: Marijke Bontenbal
Anieta M. Sieuwerts
Harry A. Peters
Wim L.J. van Putten
John A. Foekens
Jan G.M. Klijn
Publication date: 01-09-1998
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/1998
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1006026015448

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/1998

Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells

mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors

c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value

Adrenal androgens and human breast cancer: A new appraisal

Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study

Letter to the editor

Keynote webinar | Spotlight on antibody–drug conjugates in cancer